What claims are risky for skincare in the UK, and how do we avoid medical claims?

In the UK, risky skincare claims include those implying medical effects like 'treats' or 'cures' diseases. Avoid by using cosmetic-only claims such as 'hydrates' or 'refreshes,' backed by safety assessments and proper labeling to comply with UK regulations.

UK buyer view Launch planning Updated: February 26, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • Risky claims for skincare in the UK are those that suggest therapeutic, curative, or preventive properties for medical conditions, such as ‘anti-acne’ or ‘heals eczema,’ as they may be classified as medicinal products under the UK Medicines and Healthcare products Regulatory Agency (MHRA) or UK Cosmetics Regulations.
  • To avoid medical claims, stick to cosmetic functions like cleansing, moisturizing, or improving appearance, and ensure all marketing and labels are reviewed for compliance with UK-specific guidelines, including post-Brexit UKCA or retained EU standards.
  • Our factory supports this through formulation checks, where we assess ingredient lists and claim substantiation during the R&D phase, using in-house labs for stability and safety testing to provide documentation like product information files (PIFs) and safety reports.
  • For practical execution, MOQs typically start at 5,000-10,000 units per SKU, influenced by custom formulations and packaging complexity; sampling takes 4-6 weeks from RFQ approval, including claim validation and label mock-ups.
  • We integrate QA checkpoints such as microbial hold-time tests and viscosity controls to ensure consistency, and packaging is designed to avoid misleading imagery or text, with lead times of 8-12 weeks post-production for shipping, including compliance document preparation like certificates of analysis and UK-specific declarations.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).